Genetic association between human chitinases and lung function in COPD

Aminuddin, F.; Akhabir, L.; Stefanowicz, D.; Paré, P.; Connett, J.; Anthonisen, N.; Fahy, J.; Seibold, M.; Burchard, E.; Eng, C.; Gulsvik, A.; Bakke, P.; Cho, M.; Litonjua, A.; Lomas, D.; Anderson, W.; Beaty, T.; Crapo, J.; Silverman, E.; Sandford, A.
July 2012
Human Genetics;Jul2012, Vol. 131 Issue 7, p1105
Academic Journal
Two primary chitinases have been identified in humans-acid mammalian chitinase (AMCase) and chitotriosidase (CHIT1). Mammalian chitinases have been observed to affect the host's immune response. The aim of this study was to test for association between genetic variation in the chitinases and phenotypes related to chronic obstructive pulmonary disease (COPD). Polymorphisms in the chitinase genes were selected based on previous associations with respiratory diseases. Polymorphisms that were associated with lung function level or rate of decline in the Lung Health Study (LHS) cohort were analyzed for association with COPD affection status in four other COPD case-control populations. Chitinase activity and protein levels were also related to genotypes. In the caucasian LHS population, the baseline forced expiratory volume in one second (FEV) was significantly different between the AA and GG genotypic groups of the AMCase rs3818822 polymorphism. Subjects with the GG genotype had higher AMCase protein and chitinase activity compared with AA homozygotes. For CHIT1 rs2494303, a significant association was observed between rate of decline in FEV and the different genotypes. In the African American LHS population, CHIT1 rs2494303 and AMCase G339T genotypes were associated with rate of decline in FEV. Although a significant effect of chitinase gene alleles was found on lung function level and decline in the LHS, we were unable to replicate the associations with COPD affection status in the other COPD study groups.


Related Articles

  • External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? Travers, Justin; Marsh, Suzanne; Williams, Mathew; Weatherall, Mark; Caidwell, Brent; Shirtcliffe, Philippa; Aldington, Sarah; Beasley, Richard // Thorax;Mar2007, Vol. 62 Issue 3, p219 

    Background: Asthma is a heterogeneous disease with a wide range of clinical phenotypes, not all of which may be encompassed in the subjects included in randomised controlled trials (RCTs). This makes it difficult for clinicians to know to what extent the evidence derived from RCTs applies to a...

  • A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology. Gosman, Margot M. E.; Boezen, H. Marike; Van Diemen, Cleo C.; Snoeck-Stroband, Jiska B.; Slapperre, Thérëse; Hiemsfra, Pieter S.; Ten Hacken, Nick H. T.; Stolk, Jan; Postma, Dirkje S. // Thorax;Mar2007, Vol. 62 Issue 3, p242 

    Background: Chronic obstructive pulmonary disease (COPD) is a respiratory disorder with increasing prevalence and mortality. It is associated with airway obstruction, increased airway hyper-responsiveness (AHR), and ongoing airway and lung inflammation dominated by CD8 lymphocytes and...

  • Adam33 polymorphisms are associated with COPD and lung function in long-term tobacco smokers. Sadeghnejad, Alireza; Ohar, Jill A.; Zheng, Siqun L.; Sterling, David A.; Hawkins, Gregory A.; Meyers, Deborah A.; Bleecker, Eugene R. // Respiratory Research;2009, Vol. 10, p1 

    Background: Variation in ADAM33 has been shown to be important in the development of asthma and altered lung function. This relationship however, has not been investigated in the population susceptible to COPD; long term tobacco smokers. We evaluated the association between polymorphisms in...

  • Prediction of Long-Term Benefits of Inhaled Steroids by Phenotypic Markers in Moderate-to-Severe COPD: A Randomized Controlled Trial. Snoeck-Stroband, Jiska B.; Lapperre, Therese S.; Sterk, Peter J.; Hiemstra, Pieter S.; Thiadens, Henk A.; Boezen, H. Marike; ten Hacken, Nick H. T.; Kerstjens, Huib A. M.; Postma, Dirkje S.; Timens, Wim; Sont, Jacob K.; null, null // PLoS ONE;12/10/2015, Vol. 10 Issue 12, p1 

    Background: The decline in lung function can be reduced by long-term inhaled corticosteroid (ICS) treatment in subsets of patients with chronic obstructive pulmonary disease (COPD). We aimed to identify which clinical, physiological and non-invasive inflammatory characteristics predict the...

  • A Genome-Wide Association Study of Pulmonary Function Measures in the Framingham Heart Study. Wilk, Jemma B.; Ting-hsu Chen; Gottlieb, Daniel J.; Walter, Robert E.; Nagle, Michael W.; Brandler, Brian J.; Myers, Richard H.; Borecki, Ingrid B.; Silverman, Edwin K.; Weiss, Scott T.; O'Connor, George T. // PLoS Genetics;Mar2009, Vol. 5 Issue 3, p1 

    The ratio of forced expiratory volume in one second to forced vital capacity (FEV1/FVC) is a measure used to diagnose airflow obstruction and is highly heritable. We performed a genome-wide association study in 7,691 Framingham Heart Study participants to identify single-nucleotide polymorphisms...

  • Genetic Polymorphisms of Surfactant Protein D rs2243639, Interleukin (IL)-1β rs16944 and IL-1RN rs2234663 in Chronic Obstructive Pulmonary Disease, Healthy Smokers, and Non-Smokers. Issac, Marianne; Ashur, Wafaa; Mousa, Heba // Molecular Diagnosis & Therapy;Jun2014, Vol. 18 Issue 3, p343 

    Background and Objectives: Chronic obstructive pulmonary disease (COPD) is a complex chronic inflammatory disease that involves the activity of various inflammatory cells and mediators. It has been suggested that susceptibility to COPD is, at least in part, genetically determined. The primary...

  • Usefulness of peak expiratory flow measurements: is it just a matter of instrument accuracy? Brusasco, V. // Thorax;May2003, Vol. 58 Issue 5, p375 

    Editorial. Argues on the use of peak expiratory flow (PEF) as a main or sole measure of lung function, incorporated in the guidelines for diagnosis and management of asthma. Lack of usefulness of PEF in asthma monitoring; PEF measurements' possibility of detecting deterioration in airway...

  • COMPLICATED BRONCHIAL ASTHMA.  // Cortlandt Forum;06/25/2001, Vol. 14 Issue 6, p83 

    Answers queries on complicated bronchial asthma of patients with restrictive component on pulmonary function testing in Lorain County, Ohio. Causes of the asthma; Determination on the relation between obstructive and restrictive components; Evaluation of lung disease.

  • Tiotropium vs. Salmeterol in the Treatment of COPD. Miller, Karl E. // American Family Physician;12/1/2002, Vol. 66 Issue 11, p2155 

    Discusses the study 'A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patient treated with tiotropium or salmeterol,' by J.F. Donohue et al., from the July 2002 issue of 'Chest.'


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics